Neoadjuvant Chemotherapytreatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT05522985 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma
Neoadjuvant Chemotherapy

Interventions

DRUG: Triprilimab combined with TP

Sponsor

Tianjin Medical University Cancer Institute and Hospital